As previously disclosed, the company is updating 2025 financial guidance to reflect the Passenger business divestiture throughout all periods in 2025. Beginning with the Q3 2025 earnings report, the Passenger business will be reported in discontinued operations. For the full year 2025: Revenue of $160-170M; Double-digit Adjusted EBITDA. Adjusted unallocated corporate expenses and software development costs are expected to decrease to a quarterly run rate of approximately $3.5M in Q4 2025.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLDE:
- Blade Air Mobility completes sale of Passenger business, name change
- Ten new option listings and three option delistings on August 29th
- Blade Air Mobility sets timing for name change to Strata Critical Medical
- Third Point discloses activist 6.1% stake in Blade Air Mobility
- CRSP, TWST: Cathie Wood Bets Millions on Biotech, Continues Dumping Roblox